A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis
Status:
Unknown status
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a phase II double blind multicenter randomized placebo-controled clinical study aimed
to find out whether treatment with Filtrum-STI (orally administered 0,4g tablets) is safe and
effective in children with viral gastroenteritis. Filtrum-STI (lignin hydrolytic) is a drug
with a high absorbing ability, that binds and eliminates toxins, pathogenic microorganisms
and viruses. Filtrum-STI is inoffensive for mucous membranes, enhances colonic propulsion and
improves its natural microflora. The drug is not toxic and well combines with other
medication
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Avva Rus, JSC
Collaborators:
Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G. St. Vladimir Moscow Children's Clinical Hospital